This reception is for Students, Residents, Fellows-in-Training, NANOS Board of Directors members, Fellowship Directors, Student Clerkship, and Neurology and Ophthalmology Residency Directors.

The lecture will present a review of recent lawsuits alleging failure to diagnose giant cell arteritis (GCA) and the challenges of defending those claims. We will offer risk management recommendations for preventing GCA claims, including how a thorough medical history, quality of communication between staff and physicians, and coordination of care with other providers can lead to earlier diagnosis. OMIC’s sample GCA checklist will also be discussed.

Moderators:  Marc Dinkin, MD, and Meagan D. Seay, DO

This session will review a variety of up-to-date, clinically relevant, neuro-ophthalmic topics.

Presenters will discuss the utility of tPA in acute treatment of central retinal artery occlusions (CRAO) and present data from a large single-health-system regarding experience with acute treatment of CRAO. The session will then transition to physician use of social media where attendees will learn about the evolution of social media, potential adverse effects, followed by the future of social media in practice development and education. This will be followed by a presentation on ocular imaging, with focus on optical coherence tomography angiography (OCT-A) and OCT enhanced depth imaging (EDI), along with a flash overview of additional future clinically useful imaging modalities. The session will wrap up with two presentations on visual snow syndrome, including appropriate workup and differential diagnoses to ensure we are not missing a secondary etiology of visual snow syndrome, along with updates on pathophysiology and treatments.

Upon completion of this sessions, participants should be able to: (1) review the latest data and real-world experience from a single-health-system regarding acute treatment of central retinal artery occlusions, (2) describe the impact that physician use of social media has, for better and worse, on patient care and education, (3) review modern ocular imaging modalities and identify use of these modalities for better patient care, and (4) review appropriate diagnostic techniques, pathophysiology, and treatment of visual snow syndrome.

7:30 am – 7:35 am                       Welcome, Peter Quiros, MD

7:35 am – 7:55 am                       Acute Therapeutic Options for CRAO: To TPA or Not? Oana M. Dumitrascu, MD, MS

7:55 am – 8:05 am                       The Real-World Experience In a Single Health System (Kaiser Protocol and Effectiveness of Protocol), Guy Jirawuthiworavong, MD, MA

8:05 am- 8:15  am                        Physician Use of Social Media - Hazards and Opportunities, Melissa W. Ko, MD, MBA, CPE

8:20 am – 8:35 am                       Ocular Imaging, EDI, OCTA and Beyond: Where Are We, What Good Is It? Randy Kardon, MD, PhD

8:35 am – 9:05 am                       Visual Snow Syndrome

8:35 am – 8:50 am                       Differential Diagnosis and Workup, Michael Vaphiades, DO

8:05 am – 9:05 am                        Pathophysiology/Treatment, Owen B. White, MD, PhD, FRACP

9:05 am – 9:30 am                       Q&A

Moderators: Claire Fraser, MBBS and Karl Golnik, MD

In this session we will hear the international perspective on the diagnosis and management of two common neuro-ophthalmic presentations. First, we will discuss a case of optic neuritis. Each speaker will approach this case from the perspective of the underlying diagnosis and associated management that is most common in their local hospitals. Our European speaker will discuss ON related to multiple sclerosis. From America and Asia ON related to myelin oligodendrocyte glycoprotein and neuro-myelitis optica will be discussed. We will hear about infective optic neuritis and the presentations seen in an Indian setting. This will highlight all major causes of optic neuritis from an international perspective and provide an insight into management of patients that might come to our clinics from different geographical areas and ethnic backgrounds. Second, we will discuss a case of idiopathic intracranial hypertension (IIH).  Our two speakers will discuss similarities and differences in management style between their institutions.  This will allow us to critically evaluate our own practices and how the experience of other centers might help in our own management.

Upon completion of this session, participants should be able to: (1) appraise different types of optic neuritis presentations, (2) employ different management strategies in patients with IIH and (3) formulate different management options depending on the type of optic neuritis.

10:00 am – 10:05 am                   Optic Neuritis (Case Presentation)

10:05 am – 10:20 am                   African/Indian Perspective – It Could Be Infective, Ambika  Selvakumar, DO, DNB

10:20 am – 10:35 am                   European Perspective – It Could Be MS, Axel Petzold, MD, PhD, FRCP, FRCPath, FRCOphth

10:35 am – 10:50 am                   Asian Perspective – It Could Be NMO, Dan Milea, MD, PhD

10:50 am – 11:05 am                   American Perspective - It Could Be MOG, Eric Eggenberger, DO, MSEpi

11:05 am – 11:15 am                   Q&A

11:15 am – 11:20 am                   IIH (Case Presentation)

11:20 am – 11:35 am                   Idiopathic Intracranial Hypertension - The US Viewpoint,  Deborah Friedman, MD

11:35 am – 11:50 am                   Idiopathic Intracranial Hypertension: Management Challenges, Susan P. Mollan, FRCOphth

11:50 am – 12:00 pm                   Q&A

Panel: Neringa Jurkute, MD, FEBO, Andrew G. Lee, MD, and Dan Milea, MD This session will use a case-based format to discuss the practical genetic testing, indications, and strategies for specific ophthalmic genetic conditions in neuro-ophthalmology. The moderator will present cases followed by short scientific talks from experts in the field of ophthalmic genetics highlighting the practical and theoretic applications of modern genetic testing. Each case will end with a practical strategy from an experienced clinician in ophthalmic genetic disorders. 

Upon completion of this session, participants should be able to: (1) define the different strategies for genetic testing for ophthalmic disorders, (2) list the best test for specific individual clinical presentations, (3) describe the pros and cons including cost for each testing strategy, and (4) list the common neuro-ophthalmic conditions that warrant consideration for genetic testing.               

1:30 pm – 1:35 pm                        Introduction, Andrew G. Lee, MD              

1:35 pm – 1:50 pm                        When to Suspect a Hereditary Condition? Dan Milea, MD             

1:50 pm – 1:55 pm                        Q&A              

1:55 pm – 2:10 pm                        Practical Applications of Genetic Testing, Neringa Jurkute, MD, FEBO   

2:10 pm – 2:15 pm                        Q&A              

2:15 pm – 2:30 pm                         Science and Advances of Genetic Testing, Dan Milea, MD and Neringa Jurkute, MD, FEBO             

2:30 pm – 2:35 pm                        Q&A              

2:35 pm – 3:05 pm                        Clinical Cases Presentation for Panel, Andrew G. Lee, MD             

3:05 pm – 3:15 pm                        Q&A and Closing

Heavy hors d’oeuvres buffet and two drink tickets included. Guest must purchase tickets for $150 per person online or onsite.

Moderators: Jeffrey Bennett, MD, PhD and Amanda D. Henderson,  MD

This neuroimmunology session is designed to provide participants with education regarding the pathophysiology of multiple sclerosis and myasthenia gravis, with an emphasis on potential treatment targets. This portion will be followed by an overview of available treatments, with a focus on treatment implementation strategies and potential neuro-ophthalmic side effects of immunomodulatory therapies.

Upon completion of this session, participants should be able to: (1) describe the neuroimmunologic mechanisms contributing to multiple sclerosis and myasthenia gravis, (2) select appropriate treatment agents for these diseases, and (3) list potential neuro-ophthalmic side effects of immune modulating therapies.

7:30 am – 7:48 am                      
MS and the Immune System, Jennifer Graves, MD, PhD, MAS

7:48 am – 8:06 am                      
MS Treatment/Immune System Targets, Robert Shin, MD

8:06 am – 8:24 am                       Neuro-Muscular Disease and the Immune System, Umapathi Thirugnanam, MD

8:24 am – 8:42 am                       Neuro – Muscular Disease Treatment, Wayne T. Cornblath, MD

8:42 am – 9:00 am                       Good Therapies Gone Bad - What the Neuro-Ophthalmologist Needs to Know, Fiona Costello, MD, FRCP

9:00 am – 9:30 am                       Q&A

Moderators: Chantal Boisver, OD, MD and Ellen B. Mitchell, MD

Because neuro-ophthalmology encompasses so many diseases, there are diverse options for a surgical practice. Even for non-surgical neuro-ophthalmologists, it is extremely important to understand the different procedures that can be performed and be aware of potential pitfalls for the patients seeking surgical alternatives. A panel of surgical neuro-ophthalmologists that perform these procedures would address different scenarios emphasizing potential pitfalls and counseling of patient.

Upon completion of this session, participants should be able to: (1) describe the pros and cons of premium intraocular lenses in patients with a history of optic neuritis, (2) identify the limitations of LASIK surgery in patients with double vision, (3) outline the challenges of lid surgery for the treatment of blepharospasm, (4) discuss the implications of a prior NAION when counseling patients undergoing cataract surgery, (5) list the indications/limitations of performing a second ONSF, and (6) summarize the medical and surgical treatment options in Thyroid Eye Disease.

10:00 am – 10:12 am                  
I Had Optic Neuritis: Can I Get a Premium Lens? Bradley Katz, MD, PhD

10:12 am – 10:24 am                  
I Have Diplopia: Can I Get LASIK? Chantal Boisvert, OD, MD

10:24 am – 10:36 am                  
I Have Blepharospasm: Can I Get Lid Surgery? What About PSP? Valerie Elmalem, MD

10:36 am – 10:48 am                  
I Had NAION: Should I Be Worried About Cataract Surgery? Anthony Arnold, MD

10:48 am – 11:00 am                   Can We Repeat an ONSF? Peter MacIntosh, MD

11:00 am – 11:12 am                   Should I Have Teprotumumab or Surgery? Alison V. Crum, MD

11:12 am – 11:30 am                   Q&A

Grant T. Liu, MD

Many of Daniel Jacobson's papers were based upon careful observations and important questions arising in neuro-ophthalmic patients he saw in his practice.  This year’s speaker, Grant Liu, has emulated this approach in his academic career.  This talk will highlight Dr. Liu’s contributions to the understanding of the demographics, designing the diagnostic criteria, and improving the management of pediatric pseudotumor cerebri syndrome.

Upon completion of this session, participants should be able to: (1) describe the demographic differences between adults and children with pseudotumor cerebri syndrome, (2) apply the reference range for CSF opening pressure in children, and (3) employ the diagnostic criteria for pediatric pseudotumor syndrome.

Moderators: Jason Peragallo, MD and Mehdi Tavakoli, MD

This symposium is co-sponsored by the American Association for Pediatric Ophthalmology and Strabismus Adult Strabismus Committee. Diplopia and strabismus are commonly encountered in neuro-ophthalmic practice. Familiarity with management of strabismus resulting from neuro-ophthalmic pathologies is important for improving outcomes and proper counseling of patients. This symposium will review strategies and describe advances in the evaluation and treatment of diplopia resulting from neuro-ophthalmic entities. Basic and advanced surgical techniques for treatment of strabismus will be discussed. 

Upon completion of this session, participants should be able to (1) describe surgical and non-surgical options for managing adult strabismus, (2) describe the management of complex strabismus in neuro-ophthalmology patients, and (3) describe advances in the evaluation of suspected cranial nerve palsies.

2:45 pm – 3:05 pm                       Basic Concepts and Surgical Management of Adult Strabismus From Neuro-Ophthalmic Entities, Alexis Flowers, MD

3:05 pm –  3:25pm                       Non-Surgical Management of Diplopia, Gena Heidary, MD, PhD

3:25 pm – 3:45 pm                       Common Disorders Confound Diagnosis of Superior Oblique Palsy, Joseph L. Demer, MD, PhD

3:45 pm – 4:05pm                        Advanced Techniques in Surgical Management of Adult Strabismus From Neuro-Ophthalmic Diseases, Linda Dagi, MD

4:05 pm – 4:15 pm        
Q&A

Join your NANOS colleagues for networking and dancing at the Annual Banquet! Abstract awards will be presented. Music and dancing begin at 7:30 pm. Guest tickets are available for purchase at $150 with online registration or onsite.

Moderators: Patricia Johnston McNussen, MD  and, Claudia Maria Prospero Ponce, MD

Neuro-Ophthalmology is a specialty that often provides a global holistic integration and understanding of visual function and its disorders: a unique problem-solving specialty. This session gives an overview of the current status, diversity reports and future of neuro-ophthalmology.

Upon completion of this session, participants should be able to: (1) Describe the current state of the neuro-ophthalmology profession in the USA, (2) identify the strategies taken by neuro-ophthalmology leaders to evolve in the areas of diversity, equity and inclusion for all, and (3) explain the benefit of including diversity, equity and inclusion in the current and future practice of neuro-ophthalmology.

7:30 am – 7:46 am                       Neuro-Ophthalmology: Where Are We? - Workforce Report

7:30 am – 7:38 am                       State of the Profession, Larry Frohman, MD

7:38 am – 7:46 am                       Mismatch in Supply and Demand, Adam DeBusk, DO

7:46 am – 7:55 am                        Q&A

7:55 am – 8:55 am                       The Diversity Benefit - NANOS Diversity Report

7:55 am – 8:05 am                       Diversity Benefit, Lynn Gordon, MD, PhD

8:05 am – 8:35 am                       Culturally Responsive Health Care Delivery, César Briceño, MD

8:35 am – 8:45 am                       Diversity Report, Ore-ofe Adesina, MD

8:45 am – 8:55 am                       Telehealth: A Potential Solution to the Workforce and Diversity Problem or Not?, Kevin E. Lai, MD

8:55 am – 9:05 am                       Q&A

9:05 am – 9:30 am                       Where Are We Going? - The Pipeline Report

9:05 am – 9:20 am                       Pipeline State of Affairs and Issues, Courtney E. Francis, MD, and Aimee Szewka, MD

9:20 am – 9:30 am                       Pipeline Solutions, Collin McClelland, MD

9:30 am – 9:35 am                       Q&A

This session will take us on a tour of the brain’s anatomy by highlighting both the normal expected brain development and the diseases that result from abnormal brain development/maturation. We will focus on clinical disease to highlight the findings of basic science research. We have chosen 6 pediatric neuro-ophthalmic diseases that provide insight into brain development and will teach the most current understanding of neuropathology/neurophysiology that effects vision.

Upon completion of this session, participants should be able to : (1) describe neuro-ophthlamic focused neuroanatomy from early neurodevelopment during embryology, (2) apply current neuroanatomic localization or physiology to common neuro-ophthlamic conditions seen in clinic, and (3) formulate research or clinical therapeutic opportunities using the current understanding of the neuroanatomy.

10:00 am – 10:40 am                   Embryology &  Result of Pathway Disruption 
Moderator: Shannon Beres, MD

10:00 am – 10:15 am                   Embryology of the Optic Nerve and Related Pathologies, Chaow Charoenkijkajorn, MD

10:15 am – 10:30 am                   Optic Nerve Hypoplasia: Controversies in Embryogenesis, Michael Brodsky, MD

10:30 am – 10:40 am                   Q&A

10:40 am – 11:20 am                   Postganglionic Tract Disruption 
Moderator: Melinda Chang, MD

10:40 am – 10:55 am                   Insights Into the Neuroanatomy of Cerebral (Cortical) Visual Impairments, Corinna Bauer, PhD

10:55 am – 11:10 am                   Transynaptic Retrograde Degeneration, Jonathan C. Horton, MD, PhD

11:10 am – 11:20 am                   Q&A

11:20 am – 12:00 pm                   Amblyopia and Strabismus 
Moderator: Jason Peragallo, MD

11:20 am – 11:35 am                   Structural Correlates of Amblyopia,  Eric Gaier, MD, PhD

11:35 am – 11:50 am                   Congenital Cranial Dysinnervation Disorders, Mary Whitman, MD

11:50 am – 12:00 pm                   Q&A